Skip to content
ACI

Albertsons Companies, Inc.

Albertsons Companies, Inc. Q4 FY2024 earnings call

April 15, 2025 · fiscal period ended 2025-02

EPS · actual vs est

$0.46 / $0.41Beat +13.5%

Revenue · actual vs est

$18.80B / $18.64BBeat +0.9%
Ask about this call

Summary

Generated 2025-04-15

Management highlights

  • Vivek Sankaran discussed his retirement and introduced Susan Morris as the new CEO. - Fourth quarter results included ID sales growth, adjusted EBITDA, and adjusted EPS. - Strategic priorities: - Driving customer growth/engagement via digital platforms: E-commerce grew 24%, loyalty membership increased, pharmacy revenue up 18%, in-store mobile feature engaged over 9M customers. - Enhancing customer value proposition: Investing in price in certain categories/markets, amplifying own brands. - Modernizing capabilities through technology: Building best-in-class tech platforms, real-time data platform, leveraging AI. - Driving transformational productivity: $1.5B in savings over 3 years, accelerating national buying, supply chain automation, warehouse management system implementation.
View in transcript ↓

Segment performance

In the fourth quarter, ID sales grew 2.3%, adjusted EBITDA was $855 million, and adjusted earnings per share was $0.46. E-commerce grew 24% in the fourth quarter and full year, with first-party sales outpacing third-party. Loyalty membership grew over 15% year-over-year to more than 45 million members, and actively engaged customers increased 12%. Pharmacy revenue increased 18% year-over-year. E-commerce penetration is now over 8% of grocery revenue. Revenue contribution: E-commerce, loyalty, pharmacy/health, and in-store mobile app are key segments driving growth.

View in transcript ↓

Guidance

  • Fiscal 2025 ID sales growth expected in the range of 1.5% to 2.5% assuming inflation 1.5% to 2%. - Adjusted EBITDA expected in the range of $3.8 billion to $3.9 billion. - Adjusted EPS expected in the range of $2.03 to $2.16. - Capital expenditures expected in the range of $1.7 billion to $1.9 billion. - Expect gradual improvement in top line trends in grocery business in the second half of 2025, aiming for long-term algorithm of 2% plus identical sales and adjusted EBITDA growing higher than that in fiscal year '26.
View in transcript ↓

Risks

Forward-looking statements involve risks and uncertainties such as market conditions, competitive environment, tariffs, and other potential market dislocations that could cause actual results to differ materially from anticipated.

View in transcript ↓

Q&A highlights

Q: Given price investments and competitive environment, update on price gaps and breadth/depth of investments?

A: Susan Morris said no dramatic shift in consumer behavior, seeing shift to value, and taking surgical approach to price investments by category/market.

Q: Assumptions on buybacks within guidance?

A: Sharon McCollam said $1.9 billion repurchase program over next three years, equating to approx $0.06 accretion in EPS each year if bought that way.

Q: Proportion of imported goods and impact of tariffs?

A: More than 90% of products domestically sourced, deployed task force to mitigate tariff impacts.

Q: Demand growth for Albertsons Media Collective and advertiser spend?

A: Nascent in Media Collective but delivering upsized growth compared to market, optimistic about 2025 goals.

Q: Key investment buckets in 2025 and EBITDA growth cadence?

A: Multifaceted investments in digital, loyalty, customer value proposition, with cadence thoughtful throughout year, expecting stronger growth in back half of 2025 towards long-term algorithm.

Q: Q1 outlook and consumer behavior?

A: Investments in first half, expecting back half payoff, no major change in consumer behavior, consumer seeking value.

Q: Pharmacy customer engagement and wallet share?

A: Pharmacy customers evolve across platforms, with 4x basket of those not shopping pharmacy, opportunity in multiple platform engagement.

Q: E-commerce profitability and growth?

A: Largest opportunity in growing sales, proximity to customers creates productivity, scale breeds productivity, expecting E-commerce to become more profitable over time.

Q: Pharmacy growth, GLP-1 impact, and wage pressure?

A: GLP-1 contributing to growth but core script volume growing, wage growth assumption similar to 2024, SG&A impacted by wage pressure.

Q: CapEx allocation, remodels, new stores, and tariffs?

A: CapEx similar to this year, half in stores, maintenance, digital platforms, AMC; handling tariffs in way that amplifies strategic priorities.

Q: Price gaps and algo by 4Q?

A: Price gaps vary by market, surgical approach to investments; working towards long-term algorithm, expecting gradual improvement towards it.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.46$0.41+13.5%
Revenue$18.80B$18.64B+0.9%

Transcript

April 15, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.